You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog
VANCOMYCIN RANDOM |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB3233 Geisinger Epic ID: 29555 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Plasma or serum | |
Preferred collection container: |
||
Specimen required: |
2 mL aliquot serum or plasma; minimum 0.2 mL. | |
Special notes: |
The date and time of the last drug dose should be written on request at the time of order. Typically peak level specimens are collected shortly after the dose is given and trough level specimens are collected shortly before the dose is given. Refer to your prescribing pharmacy for specific information on how drug doses are to be administered along with timing of specimen collection. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection. | |
Transport temperature: |
Refrigerated (preferred) or frozen. | |
Specimen stability: |
Room temperature: 48 hours. Refrigerated: 14 days. Frozen: 1 year. | |
Rejection criteria: |
Stability limits exceeded. | |
TEST DETAILS |
||
Reference interval: |
Reference Interval: 10-40 ug/mL. | |
Critical values/courtesy alerts: |
> 80 mcg/mL. | |
CPT code(s): |
80202 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Random vancomycin, vancomycin last dose time, vancomycin last dose date. | |
Methodology: |
Enzyme Immunoassay (EIA) |
|
Synonyms: |
RVANCO
|
|
Clinical significance: |
Vancomycin is an antibiotic used in the treatment of serious bacterial infections, especially methicillin-resistant staphylococci. Vancomycin is also used in treatment for penicillin-allergic patients who cannot receive or have failed to respond to other drugs, including the penicillins and/or cephalosporins and for other infections caused by vancomycin-susceptible organisms. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |
Performing Locations
Geisinger Wyoming Valley Medical Center